0001622240-14-000001.txt : 20141020 0001622240-14-000001.hdr.sgml : 20141020 20141020114520 ACCESSION NUMBER: 0001622240-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20141020 DATE AS OF CHANGE: 20141020 EFFECTIVENESS DATE: 20141020 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Supreme Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001622240 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-226751 FILM NUMBER: 141163384 BUSINESS ADDRESS: STREET 1: SUITE #430, 580 HORNBY STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3B6 BUSINESS PHONE: 604-674-2191 MAIL ADDRESS: STREET 1: SUITE #430, 580 HORNBY STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 3B6 D 1 primary_doc.xml X0707 D LIVE 0001622240 Supreme Pharmaceuticals Inc. SUITE #430, 580 HORNBY STREET VANCOUVER A1 BRITISH COLUMBIA, CANADA V6C 3B6 604-674-2191 BRITISH COLUMBIA, CANADA None None Corporation true David Stadnyk Suite #430 580 Hornby Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 3B6 Executive Officer Director George Tsafalas Suite #430 580 Hornby Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 3B6 Director Allan Levien Suite #430 580 Hornby Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 3B6 Director Tatiana Kovaleva Suite #430 580 Hornby Street Vancouver A1 BRITISH COLUMBIA, CANADA V6C 3B6 Executive Officer Other Health Care Decline to Disclose 06b false 2014-09-19 false true false 0 525800 525800 0 false 7 0 0 0 false Supreme Pharmaceuticals Inc. David Stadnyk David Stadnyk Chair, President and CEO 2014-10-15